Endophthalmitis following open-globe injuries

Current Opinion in Ophthalmology

Volumn 9, Issue 3, 1998, Pages 59-65

  Duch Samper, Antonio M ^a,b   Chaqués Alepuz, Vicente ^a,b   Menezo, Jose L ^c   Hurtado Sarrió, Mercedes ^d  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b Residencial I Casa 7 ^*  (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d Hospital de Elda   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; FOSFOMYCIN; IMIPENEM; PIPERACILLIN; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

BACILLUS; CLINICAL PROTOCOL; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENDOPHTHALMITIS; EYE INJURY; HUMAN; INFECTION RISK; INTRAOCULAR FOREIGN BODY; INTRAVENOUS DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; VITRECTOMY;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; EYE FOREIGN BODIES; EYE INFECTIONS, BACTERIAL; EYE INJURIES, PENETRATING; HUMANS; ORBIT; PROGNOSIS; RISK FACTORS;

EID: 0031852327     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199806000-00011     Document Type: Review

References (72)

1. Duch-Samper AM, Menezo JL, Hurtado-Sarrió M: Endophthalmitis following penetrating eye injuries. Acta Ophthalmol Scand 1997, 75:104-106.
2. Ariyasu RG, Kumar S, Labree LA, Wagner DG, Smith RE: Microorganisms cultured from the anterior chamber of ruptured globes at the time of repair. Am J Ophthalmol 1995, 119:181-188.
3. Feist RM, Lim JI, Joondeph BC, Pflugfelder SC, Mieler WF, Ticho BM, Resnick K: Penetrating ocular injury from contaminated eating utensils. Arch Ophthalmol 1991, 109:63-66.
4. Mieler WF, Ellis MK, Williams DF, Han DP: Retained intraocular foreign bodies and endophthalmitis. Ophthalmology 1990, 97:1532-1538.
5. Thompson WS, Rubsamen PE, Schiffman J, Cousins SW: Endophthalmitis after penetrating ocular trauma: risk factors and visual acuity outcomes. Ophthalmology 1995, 102:1696-1671.
6. Rubsamen PE, Cousins SW, Martinez JA: Impact of cultures in management decisions following surgical repair of penetrating ocular trauma. Ophthalmic Surg Lasers 1997, 28:43-49. A prospective study of 70 consecutive patients with penetrating ocular trauma for whom intraoperative cultures were obtained. Twenty patients (29%) had positive cultures but only nine (13%) were diagnosed with clinical endophthalmitis. Seven (78%) of these nine patients with clinical endophthalmitis had positive cultures. Positive culture results directly influenced management decisions in cases with clinical evident endophthalmitis. However, routine intraoperative bacterial cultures did not help to identify patients in whom endophthalmitis would develop.
7. Bartz-Schmidt KU, Bermig J, Kirchhof B, Wiedemann P, Walter P, Heimann K: Prognostic factors associated with the visual outcome after vitrectomy for endophthalmitis. Graefes Arch Clin Exp Ophthalmol 1996, 234:S51-S58.
8. Verbraeken H: Treatment of postoperative endophthalmitis. Ophthalmologica 1995, 209:165-171.
9. Thompson JT, Parver LM, Enger CL, Mieler WF, Uggett PE for the National Eye Trauma System: Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies: National Eye Trauma System. Ophthalmology 1993, 100:1468-1474.
10. Khani SC, Mukai S: Posterior segment intraocular foreign bodies. Int Ophthalmol Clin 1995, 25:151-161.
11. Boldt HC, Pulido JS, Blodi CF, Folk JC, Weingeist TA: Rural endophthalmitis. Ophthalmology 1989, 96:1722-1726.
12. Thompson CG, Griffits RKS, Nardi W, Tester MP, Noble MJ, Cottee L, Weir P: Penetrating eye injuries in rural New South Wales. Aust N Z J Ophthalmol 1997, 25:37-41.
13. Bron A: Endophtalmies. Première partie: le diagnostic. J Fr Ophtalmol 1996, 19:225-240.
14. Cox MS, Hassan TS: Management of posterior segment trauma. In Duane, Clinical Ophthalmology, vol 6. Edited by Tasman W, Jaeger EA. Philadelphia: Lippincott-Raven Publishers; 1995:66.
15. Levin MR, D'Amico DJ: Traumatic endophthalmitis. In Eye Trauma, vol. 23. Edited by Singleton B, Hersh PS, Kenyon KR. St. Louis: Mosby-Year Book; 1991:242-252.
16. Liotet S, Warnet VN, Zrouba F, Latte J: Bacteriologie des corps etrangers intra-oculaires. Bull Med Soc Fr Ophtalmol 1984, 95:426.
17. Miyanaga Y: A new perspective in ocular infection and the role of antibiotics. Ophthalmologica 1997, 211(suppl 1):9-14. Fifteen percent to 20% of Staphylococcus epidermidis strains isolated from human conjunctiva exhibit slime formation and may be pathogens causing inflammation. Topical application, for example, eye drops, of a combination of two antimicrobial agents is usally applied to treat such infections. Any antimicrobial agent having a postantibiotic effect is generally administered in a twice-a-day regimen.
18. Hara J, Yasuda F, Higashitsutsumi M: Preoperative disinfection of the conjunctival sac in cataract surgery. Ophthalmologica 1997, 211(suppl 1):62-67.
19. Kramer A, Behrens-Baumann W: Prophylactic use of topical anti-infectives in ophthalmology. Ophthalmologica 1997, 211(suppl 1):68-76.
20. Kramer M, Hart L, Miller JW: Ultrasonography in the management of penetrating ocular trauma. Int Ophthalmol Clin 1995, 35:181-192.
21. Seawright AA, Bourke RD, Gray PJ, Cooling RJ: Intravitreal cilia in phakic penetrating eye injury. Aust N Z J Ophthalmol 1997, 25:133-135.
22. Mieler WF, Mittra RA: The role and timing of pars plana vitrectomy in penetrating ocular trauma. Arch Ophthalmol 1997, 115:1191-1192. Almost all surgeons agree that immediate vitrectomy is indicated in the management of post-traumatic endophthalmitis and intraocular foreign bodies with their attendant risk of infection. Timing for other scenarios is less clear, however. Mieler and Mittra [22••], after analysis of all available information, generally perform vitrectomy at approximately 7 to 10 days after penetrating ocular trauma.
23. Chitkara DK, Manners T, Chapman F, Stoddart MG, Hill D, Jenkins D: Lack of effect of preoperative norfloxacin on bacterial contamination of anterior chamber aspirates after cataract surgery. Br J Ophthalmol 1994, 78:772-774.
24. Duch-Samper AM, Menezo JL, Hurtado-Sarrió M, Maldonado MJ, Checa-Flores S, Diaz-Llopis M: Anterior chamber contamination following uncomplicated cataract surgery: comparative results using intravenous imipenem. Ophthalmic Surg Lasers 1996, 27:1005-1011.
25. Liesegang TJ: Prophylactic antibiotics in cataract operations. Mayo Clin Proc 1997, 72:149-159.
26. Tshefu X, Zimmerli W, Waldvogel FA: Short-term administration of rifampicin in the prevention or eradication of infection due to foreign bodies. Rev Infect Dis 1983, 5:474-480.
27. Sanderson PJ: Antimicrobial prophylaxis in surgery: microbiological factors. J Antimicrob Chemother 1993, 13(suppl B):1-9.
28. Ahnoux-Zabsonre A, Keita C, Safede K: Traumatismes oculaires graves de l'enfant au CHU de Cocody d'Abidjan en 1994. J Fr Ophtalmol 1997, 20:521-526.
29. Nossov PC, Alfaro DV, Michaud ME, Winter LW, Laughlin RM, Moss ST: Intravenous cefazolin in penetrating eye injuries: a swine model. Retina 1996, 16:246-249.
30. Alfaro DV, Liggett PE: Intravenous cefazolin in penetrating eye injuries. Graefes Arch Clin Exp Ophthalmol 1994, 232:238-241.
31. Adenis JP: Faites-vous una antibioprophylaxie chirurgicale? Si oui, quel(s) antibiotique(s) utilisez-vous et pour quelles interventions? Questions a consultants. J Fr Ophtalmol 1997, 20:85-87.
32. Schech JM, Alfaro DV, Laughlin RM, Sanford EG, Briggs J, Dalgetty M: Intravenous gentamicin and ceftazidime in penetrating ocular trauma: a swine model. Retina 1997, 17:28-32. A swine model of ocular trauma was used to determine the extent of penetration of systematically administered gentamicin and ceftazidime to the vitreous cavity of traumatized and normal eyes. Ceftazidime achieved an intravitreal concentration 33 times the minimum inhibitory concentration of Haemophilus species and twice that of Pseudomonas species in traumatized eyes after systemic administration. Gentamicin did not appear to enter the traumatized eye at appreciable levels after systemic administration.
33. Yoshizumi MO, Leinward MJ, Kim J: Topical and intravenous gentamicin in traumatically lacerated eyes. Graefes Arch Clin Exp Ophthalmol 1992, 230:175-177.
34. Pearson PA, Hainsworth DP, Ashton P: Clearance and distribution of ciprofloxacin after intravitreal injection. Retina 1993, 13:326-330.
35. Verbraeken H, Verstraete A, Van De Velde E, Verschraegen G: Penetration of gentamicin and ofloxacin in human vitreous after systemic administration. Graefes Arch Clin Exp Ophthalmol 1996, 234:S59-S65.
36. Donahue SP, Kowalski RP, Eller AW, De Varo JM, Jewart BH: Empiric treatment of endophthalmitis. Are aminoglycosides necessary? Arch Ophthalmol 1994, 112:45-53.
37. Meredith TA, Aguilar EH, Shaarawy A, Kincaid M, Dick J, Niesman MR: Vancomycin levels in the vitreous cavity after intravenous administration. Am J Ophthalmol 1995, 119:774-778.
38. Saitoh A, Jinbayashi H, Saitoh AK, Ohira A, Amemiya T, Etoh K, Matsuyama K, Ichikawa M: Parameter estimation and dosage adjustment in the treatment with vancomycin of meticillin-resistant Staphylococcus aureus ocular infections. Ophthalmologica 1997, 211:232-235. In this study, the authors present a way of administration planning for each patient based on personal data. They employed the Sawchuck-Zaske equation to calculate vancomycin clearance (CL) and volume of distribution (Vd) on the basis of three different plasma concentrations of vancomycin, and they used CL and Vd values as prior information before employing the parameter estimation and dosage adjustment program to treat a patient with postsurgical endophthalmitis caused by meticillin-resistant Staphylococcus aureus.
39. El Baba FZ, Trousdale MD, Gauderman WJ, Wagner DG, Liggett PE: Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology 1992, 99:483-486.
40. Alfaro DV, Hudson SJ, Rafanan MM, Moss ST, Levy SP: The effect of trauma on the ocular penetration of intravenous ciprofloxacin Am J Ophthalmol 1996, 122:678-683.
41. Lesk MR, Anlmann H, Marcil G, Vinet B, Lamer L, Sebag M: The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans. Am J Ophthalmol 1993, 115:623-628.
42. Doft BH, Barza M: Optimal management of postoperative endophthalmitis and results of the endophthalmitis vitrectomy study. Curr Opin Ophthalmol 1996, 7:84-94.
43. Alfaro DV, Hudson SJ, Steele JJ, Bevin AA, Mines M, Laughlin RM, Schoderbek RJ: Experimental post-traumatic Bacillus cereus endophthalmitis in a swine model: efficacy of intravitreal ciprofloxacin, vancomycin and imipenem. Retina 1996, 16:317-323.
44. El-Massry A, Meredith TA, Aguilar HE, Shaarawy A, Kincaid M, Dick J, Mahmoud MIE: Aminoglycoside levels in the rabbit vitreous cavity after intravenous administration. Am J Ophthalmol 1996, 122:684-689.
45. Alfaro DV, Roth D, Liggett PE: Post-traumatic endophthalmitis: causative organisms, treatment and prevention. Retina 1994, 14:206-211.
46. Reynolds DS, Flynn HW Jr: Endophthalmitis after penetrating ocular trauma. Curr Opin Ophthalmol 1997, 8:32-38. A review of endophthalmitis following open-globe injuries. Risk factors for infection include retained intraocular foreign body, a rural setting, delay in primary wound closure, and disruption of the crystalline lens. Treatment includes intravitreal, periocular, and systemic antibiotics. Recent and past literature supporting these recommendations, as well as the authors specific prevention and treatment protocols for post-traumatic endophthalmitis, are discussed in this review.
47. Peyman GA, Carroll CP, Raichand M: Prevention and management of traumatic endophthalmitis. Ophthalmology 1980, 87:320-324.
48. Townsend-Pico WA, Meyers SM, Langston RHS, Costin JA: Coagulase-negative Staphytococcus endophthalmitis after cataract surgery with intraocular vancomycin [letter]. Am J Ophthalmol 1996, 121:318-319.
49. Feys J, Salvanet-Bouccara A, Emond JPh, Dublanchet A: Vancomycin prophylaxis and Intraocular contamination during cataract surgery. J Cataract Retract Surg 1997, 23:894-897.
50. Gritz DC, Cevallos AV, Smolin G, Whitcher JP: Antibiotic supplementation of intraocular irrigating solutions: an in vitro model of antibacterial action. Ophthalmology 1996, 103:1204-1209. The authors developed an in vitro model to evaluate antibacterial effects of antibiotics in infusion solutions. Suspensions of some organisms were incubated for 30, 60, and 120 minutes at room temperature with vancomycin or gentamicin. Most of the organisms were not affected by exposure to the antibiotics for up to 140 minutes. Exposure to antibiotics for a short period of time such as during intraocular surgery generally has no effect on organisms commonly responsible for endophthalmitis.
51. Barequet I, Kim KB, O'Brien TP: Antibacterial effect of povidone-iodine supplementation at the conclusion of experimental cataract surgery. Invest Ophthalmol Vis Sci 1997, 38:4:S144. The authors study the effect of intracameral povidone-iodine 0.001% in reducing bacterial colonization in experimental cataract surgery. In an experimental in vitro model, the anterior chambers were inoculated with Staphylococcus aureus and Pseudomonas aeruginosa prior to surgery. There was a statistically significant (P < 0.05) difference in bacterial colonization in the 24 hours samples between eyes that received intracameral injection of povidone-iodine and eyes that were controls.
52. Isenberg SJ, Apt L, Yoshimori R, Pham C, Lam NK: Efficacy of topical povidone-iodine during the first week after ophthalmic surgery. Am J Ophthalmol 1997, 124:31-35. In the first postoperative day, povidone-iodine ophthalmic solution prevented increases in conjunctival bacterial colony-forming units and decreased the species compared with cases treated with antibiotic. The authors determined whether these beneficial effects of povidone-iodine could be sustained during the first postoperative week. They concluded that povidone-iodine ophthalmic solution is an alternative to postoperative topical antibiotics because of its effectiveness in controlling conjundival bacterial colony-forming units and species, its relatively low cost, and its availability.
53. The Endopthalmitis Vitrectomy Study Group: Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol 1996, 112:830-846.
54. Alfaro DV, Roth DB, Laughlin RM, Goyal M, Liggett PE: Paediatric posttraumatic endophthalmitis. Br J Ophthalmol 1995, 79:888-891.
55. Johnson MW, Doft BM, Kelsey SF, Barza M, Wilson LA, Barr CC, Wisniewsky GR, The Endophthalmitis Vitrectomy Study Group: The endophthalmitis vitrectomy study: relationship between clinical presentation and microbiologic spectrum. Ophthalmology 1997, 104:261-272. Baseline factors correlating with higher rates of both gram-negative and other gram-positive isolates were corneal infiltrate, cataract wound abnormalities, afferent pupillary defect, loss of red reflex, initial light perception-only vision, and symptom onset within 2 days of surgery. Gram-negative organisms did not grow in any eyes in which a retinal vessel could be visualized, and 61.9% of these eyes had equivocal or no growth. Diabetes mellitus was associated with a higher yield of gram-positive, coagulase-negative microccoci. Eye pain was not a discriminator for culture results.
56. Barza M, Pavan PR, Doft BH, Wisniewski SR, Wilson LA, Han DP, Kelsey SF: Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the endophthalmitis vitrectomy study. Arch Ophthalmol 1997, 115:1142-1150.
57. Haimann MH, Weiss H, Miller J: The endophthalmitis vitrectomy study [correspondence]. Arch Ophthalmol 1996, 114:1025.
58. Joondeph BC, Flynn HW Jr, Miller D, Joondeph HC: A new culture method for infectious endophthalmitis. Arch Ophthalmol 1989, 107:1334-1337
59. Endophthalmitis Vitrectomy Study Group: Results of the endophthalmitis vitrectomy study: a randomized trial of immediated vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995, 113:1479-1496.
60. Pavan PR, Oteiza EE, Hughes BA, Avni A: Exogenous endophthalmitis initially treated without systemic antibiotics. Ophthalmology 1994, 101:1289-1297.
61. O'Day DM, Jones DB, Patrinelly J, Elliot JH: Staphylococcus epidermidis endophthalmitis: visual outcome following noninvasive therapy. Ophthalmology 1982, 89:354-360.
62. Aguilar HE, Meredith TA, El-Massry A, Shaarawy A, Kincaid M, Dick J, Ritchie DJ, Reichley RM, Neisman MK: Vancomycin levels after intravitreal infection: effects of inflammation and surgery. Retina 1995, 15:428-432.
63. Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF and the Endophthalmitis Vitrectomy Study Group: Spectrum and susceptibilities of microbiologic isolates in the endophthalmitis vitrectomy study. Am J Ophthalmol 1996, 122:1-17.
64. Okhravi N, Towler HMA, Hykin P, Matheson M, Lightman S: Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis. Br J Ophthalmol 1997, 81:719-725.
65. Mandell BA, Meredith TA, Aguilar E, El-Massry A, Sawant A, Gardner S: Effects of inflammation and surgery in amikacin levels in the vitreous cavity. Am J Ophthalmol 1993, 115:770-774.
66. Campochiaro PA, Lim JI, Aminoglycoside Toxicity Study Group: Aminoglycoside toxicity in the treatment of endophthalmitis. Arch Ophthalmol 1994, 112:48-53.
67. Flynn HW, Meredith TA. The endophthalmitis vitrectomy study [correspondence]. Arch Ophthalmol 1996, 114:1027-1028. The authors state that "omission of systemic antibiotics can reduce toxic effects, cost, and length of hospital stay." It must be strongly emphasized that a single injection of intravitreal antibiotics is not uniformly effective in eradicating bacterial endophthalmitis in either laboratory experiments or in patients. Although the best strategy for additional treatment is not known, a second intravitreal antibiotic injection may be valuable and intravenous therapy should also be considered. Intravenous therapy may be particularly useful in eyes with concomitant anterior loci of infection, such as blebitis and deep stich abscesses.
68. Abdala CA, Meredith TA, Aguilar HE, Liang CP, Hageman G: Toxicity of repeated intravitreal injections of vancomycin or ceftazidine [ARVO Abstracts]. Invest Ophthalmol Vis Sci 1995, 36(4,suppl):4719.
69. Oum BS, D'Amico DJ, Wong KW: Intravitreal antibiotic therapy with vancomycin and aminoglycoside: an experimental study of combination and repetitive injections. Arch Ophthalmol 1989, 107:1055-1060.
70. Park SS, Samiy N, Rvoff K, D'Amico DJ, Baker AS: Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits. Arch Ophthalmol 1995, 113:1324-1329.
71. Dhaliwal RS, Meredith TA: Endophthalmitis. In Ophthalmic Surgery Complications. Prevention and Management. Edited by Charlton JF, Weinstein GW. Philadelphia: JB Lippincott; 1995:409-430.
72. Pieramici DJ, Sternberg P, Aaberg TM, Bridges WZ, Capone A, Cardillo SA, DeJuan E, Kuhn F, Meredith TA, Mieler WF, Olsen TW, Rubsamen P, Stout T (The Ocular Trauma Classification Group): A system for classifying mechanical Injuries of the eye (globe). Am J Ophthalmol 1997, 123:820-831. The Ocular Trauma Classification Group, a committee of 13 ophthalmologists from seven separate institutions, was organized to discuss the standardization of ocular trauma classification. This classification system categorizes ocular injuries at the time of initial examination. It is designed to promote the use of standard terminology and assessment, with applications to clinical management and research studies regarding eye injuries.